Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19

Int J Cancer. 2020 Dec 1;147(11):3267-3269. doi: 10.1002/ijc.33148. Epub 2020 Jun 27.

Tao Liu¹, Guang Zeng^{1

2}, Huangheng Tao³, Yue Shi¹; COVID-19 in Cancer Patients Research Group^{1

4}; Ting Wang¹, Tongzu Liu¹, Fangjian Guo^{5

6}, Fuling Zhou⁷, Xinghuan Wang^{1

2}

¹ Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
² Leishenshan Hospital, Wuhan, Hubei, China.
³ State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China.
⁴ Cancer Precision Diagnosis and Treatment and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
⁵ Department of Obstetrics & Gynecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
⁶ Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
⁷ Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

No abstract available

Publication types